Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.
BACKGROUND
Enteral feeding (tube feeding) is offered to many people with amyotrophic lateral sclerosis/motor neuron disease experiencing difficulty swallowing (dysphagia) and maintaining adequate nutritional intake leading to weight loss.


OBJECTIVE
To examine the efficacy of percutaneous endoscopic gastrostomy placement or other tube feeding placement on: (1) survival;(2) nutritional status; (3) quality of life;(4) minor and major complications of percutaneous endoscopic gastrostomy.


METHODS
We searched the Cochrane Neuromuscular Disease Group Trials Register (24 November 2009), MEDLINE (from January 1966 to September 2009), and EMBASE (from January 1980 to September 2009) for all papers on enteral tube feeding in amyotrophic lateral sclerosis/motor neuron disease. The results were screened to identify randomised controlled trials and to identify non-randomized studies that might be worthy of review and discussion. We checked references in published articles and enlisted personal communications to identify any additional references.


METHODS
A priori selection criteria included randomised and quasi-randomized controlled trials evaluating the efficacy of percutaneous endoscopic gastrostomy or other feeding tube placement. Since no such trials were discovered, all prospective and retrospective controlled studies were reviewed in the 'Background' or 'Discussion' sections of the review.


METHODS
We independently assessed study design and extracted data. We considered the following outcomes: (1) survival rate in months (of primary interest), (2) nutritional status measured by weight change, change in body mass index, or other quantitative index of nutritional status, (3) self-perceived quality of life and (4) safety of the procedure as indicated by minor and major complications of surgical or radiological guided PEG tube insertion.


RESULTS
We found no randomised controlled trials comparing the efficacy of enteral tube feeding with those people who continued to eat orally, without enteral feeding. We summarized the results of retrospective and prospective studies in the 'Discussion' section.


CONCLUSIONS
There are no randomised controlled trials to indicate whether enteral tube feeding is beneficial compared to continuation of oral feeding for any of the outcome measures. The 'best' evidence to date suggests a survival advantage for some people with amyotrophic lateral sclerosis/motor neuron disease, but these conclusions are tentative. Evidence for improved nutrition is also incomplete but tentatively favorable.  Quality of life has been addressed in studies and needs more attention. Based on a number of recent non-randomized studies comparing surgical and radiographic approaches to feeding tube insertion these two procedures for PEG tube insertion appear to be equivalent.
University of Toronto Toronto General Hospital / UHN, 200 Elizabeth Street, 5EC-306 Toronto, Canada, ON M5G 2C4.
Hans Dieter
HD
Katzberg
Michael
M
Benatar
D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy; D003680:Deglutition Disorders / Q000150:complications; D004750:Enteral Nutrition; D005774:Gastrostomy; D006801:Humans; D016472:Motor Neuron Disease / Q000628:therapy*; D011446:Prospective Studies; D012189:Retrospective Studies
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
11464847
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):645-7
15026518
Neurology. 2009 Oct 13;73(15):1218-26
19822872
Neurology. 2001 Feb 13;56(3):413-4
11171915
Ugeskr Laeger. 1994 Jul 11;156(28):4138-40
7520644
Stat Med. 1998 Dec 30;17(24):2815-34
9921604
Acta Neurol Scand. 1977 Sep;56(3):194-204
906794
Neurology. 1999 Sep 22;53(5):1123-5
10496278
J Neurol Sci. 1999 Oct 31;169(1-2):128-32
10540021
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):177-85
13129795
Neurology. 2002 Jul 9;59(1):99-103
12105314
Amyotroph Lateral Scler. 2008 Jun;9(3):163-7
18574760
J Nutr Health Aging. 2000;4(1):54-7
10840479
J Neurol Sci. 1999 Oct 31;169(1-2):118-25
10540019
Neurology. 2001 Mar 27;56(6):753-7
11274310
Amyotroph Lateral Scler. 2006 Jun;7(2):67-71
16753969
Neurology. 2008 Dec 2;71(23):1889-95
19047561
J Neurol Sci. 1994 Jul;124 Suppl:96-107
7807156
Dysphagia. 1999 Summer;14(3):162-4
10341114
Neurology. 2002 Feb 12;58(3):485-7
11839859
J Neurol. 2001 Jul;248(7):612-6
11518004
J Neurol. 1998 Aug;245 Suppl 2:S13-9; discussion S29
9747929
Radiology. 2004 Nov;233(2):392-9
15459322
Neurology. 1999 Apr 22;52(7):1311-23
10227612
Radiology. 2002 Sep;224(3):713-7
12202704
Arch Neurol. 2006 Aug;63(8):1139-43
16908741
J Neurol. 2004 Jul;251(7):813-7
15258782
J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):948-50
16614011
Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):240-4
15799554
J Neurol. 1995 Oct;242(10):695-8
8568533
Rinsho Shinkeigaku. 2000 Nov;40(11):1083-9
11332187
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1(2):91-6
11467055
J Neurol Sci. 2001 Oct 15;191(1-2):35-41
11676990
Amyotroph Lateral Scler. 2007 Apr;8(2):87-9
17453635